AMANTADINE
Generic: AMANTADINE
Alembic Pharmaceuticals Inc.Manufacturer
ORALRoute
AMANTADINE HYDROCHLORIDEActive Substance
2017-06-21Original Approval
AMANTADINE is FDA application ANDA208966, sponsored by ALEMBIC. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Recalls
Class II2026-02-13
Amantadine HCl, Capsules, UPS, 100 mg, 50 Capsules (5 x 10) unit dose, Rx Only, Manufactured for: AvKARE, Pulaski, TN 38Failed Dissolution Specifications: This recall has been initiated due to an Out of Specification fin
Class II2018-03-30
Amantadine HCl Capsules, USP, 100 mg, 50 Capsules (5x10) Unite Dose, Rx Only, Manufactured for: AvKARE Inc. Pulaski, TN Failed Dissolution Specifications
Class II2021-03-15
Amantadine Hydrochloride Tablets 100 mg 100-count bottle, Rx Only Manufactured by Upsher-Smith Laboratories, Inc. Maple CGMP Deviations: Intermittent exposure to temperature excursion during storage.
Top Reported Reactions
1
FALL
1,792 reports
2
DRUG INEFFECTIVE
1,391 reports
3
FATIGUE
1,247 reports
4
HALLUCINATION
1,205 reports
5
DYSKINESIA
1,075 reports
6
GAIT DISTURBANCE
1,068 reports
7
DIZZINESS
899 reports
8
TREMOR
860 reports
9
DEATH
796 reports
10
ASTHENIA
764 reports